Drug Studies for the Heart
MERCK 0859Anacetrapib along with ongoing statin therapy with or without other lipid modifying medication in patients with hypercholesterolemia or low HDL-C. Principal Investigator: Paul Berlacher, MD Contact the research coordinator: Pam Beavers, RN, CCRC at 419-842-3547 |